BlackRock Advisors’s Immune Design Corp. IMDZ Stock Holding History

BlackRock Advisors’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$368K	Buy	66,849 +4,176	+7%	+$29.5K	﹤0.01%	2394
2016 Q3	$475K	Buy	62,673 +2,318	+4%	+$16.9K	﹤0.01%	2207
2016 Q2	$492K	Hold	60,355	–	–	﹤0.01%	2125
2016 Q1	$785K	Sell	60,355 -58	-0.1%	-$670	﹤0.01%	1860
2015 Q4	$1.21M	Sell	60,413 -1,869	-3%	-$32.2K	﹤0.01%	1624
2015 Q3	$760K	Sell	62,282 -95,729	-61%	-$1.79M	﹤0.01%	1895
2015 Q2	$3.26M	Buy	158,011 +90,972	+136%	+$2.15M	﹤0.01%	1107
2015 Q1	$1.42M	Buy	67,039 +59,400	+778%	+$1.55M	﹤0.01%	1365
2014 Q4	$235K	Buy	7,639 +5,377	+238%	+$149K	﹤0.01%	2535
2014 Q3	$40K	Buy	+2,262	New	+$28.6K	﹤0.01%	3328

Other funds holding IMDZ

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

PAI

ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock Advisors's IMDZ Position: Q4 2016 in Review

BlackRock Advisors increased its Immune Design Corp. (IMDZ) stake by 6.7% in Q4 2016, buying an estimated $29.5K and bringing the position to 66,849 shares worth $368K. The position accounts for ﹤0.01% of the portfolio, ranked #2394.

BlackRock Advisors first reported a position in IMDZ in Q3 2014 and has held it in 10 quarters since. The position peaked at $3.26M in Q2 2015. 65 funds tracked by Wall St. Rank hold IMDZ as of Q4 2016.

BlackRock Advisors held 66,849 shares of Immune Design Corp. worth $368K as of Q4 2016.
BlackRock Advisors bought 4,176 Immune Design Corp. shares in Q4 2016, an estimated $29.5K.
Immune Design Corp. made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2394 holding.
BlackRock Advisors first reported a position in Immune Design Corp. in Q3 2014 and has held it in 10 quarters since.
BlackRock Advisors's Immune Design Corp. position peaked at $3.26M in Q2 2015.
65 funds tracked by Wall St. Rank held Immune Design Corp. as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.